These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24801227)

  • 1. (99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.
    Galli F; Manni I; Piaggio G; Balogh L; Weintraub BD; Szkudlinski MW; Fremont V; Dierckx RA; Signore A
    Thyroid; 2014 Aug; 24(8):1297-308. PubMed ID: 24801227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Imaging of Thyroid Cancer with
    Galli F; Varani M; Lauri C; Campagna G; Balogh L; Weintraub BD; Szkudlinski MW; Bartolazzi A; Manni I; Piaggio G; Signore A
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33926024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
    Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F
    Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.
    Corsetti F; Chianelli M; Cornelissen B; Van de Wiele C; D'Alessandria C; Slegers G; Mather SJ; Di Mario U; Filetti S; Scopinaro F; Signore A
    Cancer Biother Radiopharm; 2004 Feb; 19(1):57-63. PubMed ID: 15068612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [
    Gimblet GR; Houson HA; Whitt J; Reddy P; Copland JA; Kenderian SS; Szkudlinski MW; Jaskula-Sztul R; Lapi SE
    Mol Pharm; 2024 Aug; 21(8):3889-3896. PubMed ID: 38976794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.
    Ma C; Xie J; Liu W; Wang G; Zuo S; Wang X; Wu F
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD008302. PubMed ID: 21069705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer.
    Podoba J
    Bratisl Lek Listy; 2010; 111(1):38-40. PubMed ID: 20429310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodide.
    Reinfelder J; Maschauer S; Foss CA; Nimmagadda S; Fremont V; Wolf V; Weintraub BD; Pomper MG; Szkudlinski MW; Kuwert T; Prante O
    Thyroid; 2011 Jul; 21(7):783-92. PubMed ID: 21568725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.
    Kowalska A; Pałyga I; Gąsior-Perczak D; Walczyk A; Trybek T; Słuszniak A; Mężyk R; Góźdź S
    PLoS One; 2015; 10(7):e0133852. PubMed ID: 26230494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy.
    Jeong SY; Lee SW; Kim WW; Jung JH; Lee WK; Ahn BC; Lee J
    Sci Rep; 2019 Apr; 9(1):5570. PubMed ID: 30944403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma.
    Giovanella L; Suriano S; Castellani M; Ceriani L; Verburg FA
    Clin Nucl Med; 2011 Sep; 36(9):781-5. PubMed ID: 21825849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Gimblet GR; Whitt J; Houson HA; Lin D; Guenter R; Rao TC; Wang D; Ness J; Gonzalez ML; Murphy MS; Gillis A; Chen H; Copland JA; Kenderian SS; Lloyd RV; Szkudlinski MW; Lapi SE; Jaskula-Sztul R
    Surgery; 2024 Jan; 175(1):199-206. PubMed ID: 37919223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of administration of rhTSH with withdrawal of thyroid hormone. Follow-up of patients with differentiated thyroid carcinoma].
    Caresia AP; Castell Conesa J; Obiols Alfonso G; Pifarré Montaner P; Negre Busó M; García Alonso C; Galofré Mora P; Mesa Manteca J
    Rev Esp Med Nucl; 2006; 25(4):236-41. PubMed ID: 16827986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences].
    Hasse-Lazar K; Handkiewicz-Junak D; Roskosz J; Szpak-Ulczok S; Krajewska J; Jurecka-Lubieniecka B; Jarzab B
    Endokrynol Pol; 2006; 57(4):445-50. PubMed ID: 17006851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.